GlassScriptPhysician profile
Shashikumar R H Gowda
NPI 1922116672
$20,127.11
in general payments reported to CMS, 2019-2025
42 companies · $1,833 in 2025
The $1,833 reported for 2025 was more than what 85% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,215 · 2020: $3,589 · 2021: $1,729 · 2022: $1,096 · 2023: $1,971 · 2024: $1,693 · 2025: $1,833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,530 · Education: $504 · Travel and Lodging: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,530.12 |
| Education | $503.94 |
| Travel and Lodging | $463.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $8,802.83 | 2019-2024 | Yupelri |
| Glaxosmithkline, LLC. | $1,858.21 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,857.17 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $1,462.41 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Grifols USA, LLC | $532.84 | 2019-2024 | Prolastin-C Liquid |
| United Therapeutics Corporation | $486.66 | 2019-2025 | Orenitram, Tyvaso, Remodulin |
| Olympus Corporation of The Americas | $463.96 | 2025 | |
| Harmony Biosciences LLC | $462.44 | 2023-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $431.29 | 2019-2024 | Dupixent |
| Jazz Pharmaceuticals INC. | $422.66 | 2019-2025 | Xywav |
| Actelion Pharmaceuticals US, INC. | $358.91 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Sunovion Pharmaceuticals INC. | $276.62 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $272.04 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $251.96 | 2021-2025 | Glassia |
| Genentech USA, INC. | $235.40 | 2019-2023 | Xolair |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $224.95 | 2020-2024 | Acthar |
| Genzyme Corporation | $196.65 | 2020-2025 | |
| Insmed, INC. | $187.35 | 2019-2025 | Arikayce, Brinsupri |
| Idorsia Pharmaceuticals US INC | $163.76 | 2023-2024 | Quviviq |
| Merck Sharp & Dohme LLC | $145.84 | 2020-2025 | Zerbaxa, Winrevair, Keytruda |
| Amgen INC. | $123.62 | 2022-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $116.49 | 2019-2023 | |
| Axsome Therapeutics, INC. | $100.00 | 2023-2025 | Sunosi |
| Philips North America LLC | $88.00 | 2019-2023 | |
| Electromed, INC. | $59.05 | 2024-2025 | Smartvest |
| Baxter Healthcare | $58.09 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| E.R. Squibb & Sons, L.L.C. | $48.43 | 2021 | |
| Advanced Respiratory, INC | $45.94 | 2019-2020 | |
| Shire North American Group INC | $45.74 | 2019 | |
| Paratek Pharmaceuticals, INC. | $45.74 | 2020-2021 | |
| Pulmonx Corporation | $44.86 | 2020-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Teva Pharmaceuticals USA, INC. | $43.67 | 2021-2023 | Airduo Digihaler |
| Sanofi-Aventis U.S. LLC | $36.32 | 2020-2021 | |
| Vifor Pharma, INC. | $30.49 | 2025 | Zemaira |
| Masimo Corporation | $22.39 | 2023 | Set and Rainbow Set |
| Becton, Dickinson and Company | $21.62 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.23 | 2020 | |
| Edwards Lifesciences Corporation | $18.05 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $16.97 | 2024 | Lumryz |
| Zoll Respicardia, INC. | $16.64 | 2025 | Remede System |
| Lilly USA, LLC | $16.18 | 2025 | Zepbound |
| Veran Medical Technologies, INC. | $15.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashikumar Gowda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.